MoneyWorks4Me

Godavari Drugs - Quaterly Results

14 Feb 2022 Evaluate
The total revenue for the quarter ended December 2021 remained nearly unchanged at Rs. 337.57 millions.Net Profit recorded in the quarter ended December 2021 rise to 32.80% to Rs. 13.32  millions  compared to R. 10.03 millions in corresponding previous quarter.The company reported a degrowth in operating Profit to 26.38 millions from 26.51 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 337.57 330.99 1.99 1168.25 897.11 30.22 1226.70 956.98 28.18
Other Income 0.53 0.82 -35.37 1.61 2.96 -45.61 4.10 3.28 25.00
PBIDT 26.38 26.51 -0.49 87.44 75.55 15.74 102.37 63.63 60.88
Interest 7.33 8.17 -10.28 22.31 24.98 -10.69 33.08 29.12 13.60
PBDT 19.05 18.34 3.87 65.13 50.57 28.79 69.29 34.51 100.78
Depreciation 4.34 2.88 50.69 12.77 8.47 50.77 12.23 11.63 5.16
PBT 14.71 15.46 -4.85 52.36 42.10 24.37 57.06 22.88 149.39
TAX 1.39 5.43 -74.40 12.60 13.69 -7.96 15.78 2.88 447.92
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 13.32 10.03 32.80 39.76 28.41 39.95 41.28 20.00 106.40
Equity 75.31 75.31 0.00 75.31 75.31 0.00 75.31 75.31 0.00
PBIDTM(%) 7.81 8.01 -2.43 7.48 8.42 -11.12 8.35 6.65 25.51
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..